Atlantic American Corp (NASDAQ:AAME) has been relatively unchanged settling at $2.04 with a light volume of 12,857 shares. For the past two weeks the stock has been trading between $1.06 and $2.25. Company has a market capitalization of $44 million and a trailing 12 month P/E ratio of $37.74.
Atlantic American Corporation is a holding company, which operates through its subsidiaries in well-defined specialty markets within the life and health and property and casualty insurance industries. The Company's principal operating subsidiaries are American Southern Insurance Company and American Safety Insurance Company within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company (Bankers Fidelity) within the life and health industry.
Crocs (NASDAQ:CROX) has lost 2.49% or $.44 to settle at $17.21 with a 2.1 million shares volume. For the past 52 weeks the stock has been trading between $6.95 and $19.54. Company has a market capitalization of $1.52 billion and a trailing 12 month P/E ratio of 22.64.
Crocs, Inc. is a designer, manufacturer, distributor, worldwide marketer and brand manager of footwear for men, women, and children. The Company designs and sells an offering of footwear, apparel, gear and accessories that utilize its closed cell-resin, called Croslite. The Crocs footwear products are divided into four categories: Core, Active, Casual and Style.
Ameresco, Inc. (NYSE:AMRC) has lost 2.29% or $.33 to settle at $14.09 a share with a volume of 121,000 shares compared to its three-month average volume of 186,000 shares. For the past 52 weeks the stock has been trading between $11.51 and $17.46. Company has a market capitalization of $579 million and a trailing 12 month P/E ratio of 20.42.
Ameresco, Inc. (Ameresco) is a provider of energy efficiency solutions for facilities throughout North America. The Company's solutions enable customers to reduce their energy consumption, lower their operating and maintenance costs and realize environmental benefits. Ameresco operates in four segments: U.S. federal, central U.S. region, other U.S. regions and Canada.
Mylan Inc. (NASDAQ:MYL) has lost 0.87% or $.20 to settle at $22.67 a share with an increased volume of 10.4 million shares compared to its average three-month volume of 6 million shares. For the past 52 weeks the stock has been trading between $16.55 and $24.17. Company has a market capitalization of $8.44 billion and a trailing 12 month P/E ratio of 33.34.
Mylan Inc. (Mylan) is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). It operates through two business segments: Generics and Specialty. The Generics Segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule or transdermal patch form, as well as API. The Specialty Segment engages mainly in the manufacture and sale of branded specialty nebulized and injectable products.
Textron Inc. (NYSE:TXT) has lost 3.1% or $.84 a share to settle at $26.25 with a volume of 5.6 million shares. For the past 52 weeks the stock has been trading between $15.88 and $28.87. Company has a market capitalization of $8.1 billion and a trailing 12 month P/E ratio of 92.43.
Textron Inc. is a multi-industry company with a global network of aircraft, defense, industrial and finance businesses to provide customers with products and services worldwide. It conducts its business through five operating segments: Cessna, Bell, Textron Systems and Industrial, which represents its manufacturing businesses, and Finance, which represents its finance business.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report
